Quantcast

Latest Biomarker Stories

2014-10-22 20:23:21

LONDON, Oct. 22, 2014 /PRNewswire/ -- This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 280 tables & figures over 232 pages. The personalized medicine (global) market is presented as follows: -- By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD, FOUNDATION MEDICINE, GENOMIC HEALTH)-- By Geography...

2014-10-22 08:33:04

HAMILTON, N.J., Oct. 22, 2014 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, CAP-accredited laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announces that it is now offering new Cystic Fibrosis Testing which utilizes cutting edge technology, including next- generation DNA sequencing platforms. Cystic fibrosis (CF), or mucoviscidosis, is a genetically inherited multisystem disorder that...

2014-10-21 12:29:40

However, Restrictions in Drug Coverage and Molecular Testing Limit Patient Access to Biomarker-Associated Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the majority of surveyed oncologists in Argentina and Mexico are primarily prescribing biomarker-driven agents for the treatment of HER2-positive breast cancer and EGFR-mutation positive metastatic, non-small-cell lung cancer (NSCLC). However,...

2014-10-20 08:32:33

Variety of bio-marker collection and analysis processes to be assessed for use in printed sensor system SAN JOSE, Calif., Oct. 20, 2014 /PRNewswire/ -- The Nano-Bio Manufacturing Consortium (NBMC), an industry-academia partnership with the United States Air Force Research Laboratory (AFRL), has chosen a project proposed by the Arizona Center for Integrative Medicine (AzCIM) at the University of Arizona College of Medicine - Tucson, to receive research funding. The AzCIM project's...

2014-10-14 16:25:50

LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018. This report provides:An overview of the global market for signal transduction therapies and inhibitorsAnalyses of global market trends, with...

2014-10-14 08:32:24

-New Preclinical Results Increase Mechanistic Understanding of Targeting miR-103/107 for Metabolic Disorders and miR-21 for Renal Dysfunction in Alport Syndrome Patients- LA JOLLA, Calif., Oct. 14, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will present new preclinical data on multiple programs and an overview of its clinical portfolio at...

2014-10-13 23:08:26

The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) October 13, 2014 The “Metabolomics Market - By Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy,...

2014-10-07 23:05:36

According to new report from BCC Research, the global market for next generation (next gen) cancer diagnostics is expected to grow to $10.6 billion by 2019, with a five-year compound annual growth rate (CAGR) of 42.6%. Wellesley, Mass. (PRWEB) October 07, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, NEXT GENERATION CANCER DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for next generation (next gen) cancer diagnostics is expected to grow to...

2014-10-07 12:31:04

GHENT, Belgium and MADRID, October 7, 2014 /PRNewswire/ -- MyCartis today announced the launch of Evalution(TM), a multiplex biomarker analysis platform for the life sciences research market. Evalution(TM) is MyCartis' digital multiplex analysis platform tailored to clinical research and pharmaceutical markets and designed to analyze a broad range of protein and nucleic acid-based biomarkers, delivering high quality data and rapid results. Evalution(TM) provides an...

2014-10-03 12:25:41

Circulating metabolite could predict abnormalities in body's response to a 'glucose challenge' as substitute for oral glucose tolerance test (OGTT) RICHMOND, Va., Oct. 3, 2014 /PRNewswire/ -- Could a single serum biomarker predict risk for diabetes as accurately as a more complex, hours-long diagnostic procedure? According to researchers at Health Diagnostic Laboratory, Inc. (HDL, Inc.) and the University of Utah, the answer is "yes." In a newly published study, the scientists...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.